Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model

Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model

Metabolic syndrome (MetS), a cluster of metabolic conditions that include obesity, hyperlipidemia, and insulin resistance, increases the risk of several aging-related brain diseases, including Alzheimer’s disease (AD). However, the underlying mechanism explaining the link between MetS and brain func...

Full description

Bibliographic Details
Main Authors: Pedro Cisternas, Camila Gherardelli, Joel Gutierrez, Paulina Salazar, Carolina Mendez-Orellana, G. William Wong, Nibaldo C. Inestrosa
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
adiponectin
resistin
obesity
Alzheimer´s disease
glucose metabolism
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1237796/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1237796/full

Similar Items